chr2-218275565-G-C
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_022152.6(TMBIM1):āc.846C>Gā(p.Pro282Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.391 in 1,613,430 control chromosomes in the GnomAD database, including 125,040 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.36 ( 10013 hom., cov: 33)
Exomes š: 0.40 ( 115027 hom. )
Consequence
TMBIM1
NM_022152.6 synonymous
NM_022152.6 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -9.03
Genes affected
TMBIM1 (HGNC:23410): (transmembrane BAX inhibitor motif containing 1) Enables death receptor binding activity. Involved in negative regulation of Fas signaling pathway; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; and negative regulation of protein localization to plasma membrane. Located in Golgi apparatus; endosome membrane; and lysosomal membrane. [provided by Alliance of Genome Resources, Apr 2022]
PNKD (HGNC:9153): (PNKD metallo-beta-lactamase domain containing) This gene is thought to play a role in the regulation of myofibrillogenesis. Mutations in this gene have been associated with the movement disorder paroxysmal non-kinesigenic dyskinesia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 2-218275565-G-C is Benign according to our data. Variant chr2-218275565-G-C is described in ClinVar as [Benign]. Clinvar id is 1264824.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-9.03 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.423 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMBIM1 | NM_022152.6 | c.846C>G | p.Pro282Pro | synonymous_variant | 12/12 | ENST00000258412.8 | NP_071435.2 | |
PNKD | NM_015488.5 | c.236+4016G>C | intron_variant | ENST00000273077.9 | NP_056303.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMBIM1 | ENST00000258412.8 | c.846C>G | p.Pro282Pro | synonymous_variant | 12/12 | 1 | NM_022152.6 | ENSP00000258412.3 | ||
PNKD | ENST00000273077.9 | c.236+4016G>C | intron_variant | 1 | NM_015488.5 | ENSP00000273077.4 |
Frequencies
GnomAD3 genomes AF: 0.356 AC: 54151AN: 152008Hom.: 10012 Cov.: 33
GnomAD3 genomes
AF:
AC:
54151
AN:
152008
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.384 AC: 96341AN: 250646Hom.: 18822 AF XY: 0.384 AC XY: 52052AN XY: 135494
GnomAD3 exomes
AF:
AC:
96341
AN:
250646
Hom.:
AF XY:
AC XY:
52052
AN XY:
135494
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.395 AC: 577380AN: 1461304Hom.: 115027 Cov.: 46 AF XY: 0.394 AC XY: 286722AN XY: 726950
GnomAD4 exome
AF:
AC:
577380
AN:
1461304
Hom.:
Cov.:
46
AF XY:
AC XY:
286722
AN XY:
726950
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.356 AC: 54165AN: 152126Hom.: 10013 Cov.: 33 AF XY: 0.354 AC XY: 26337AN XY: 74348
GnomAD4 genome
AF:
AC:
54165
AN:
152126
Hom.:
Cov.:
33
AF XY:
AC XY:
26337
AN XY:
74348
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 14, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at